| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 30,000 | 01 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | 01 Oct 2025 | 1 | $0 | 4 | Director | 02 Oct 2025, 18:28 |
| KALV | KalVista Pharmaceuticals, Inc. | 03 Oct 2024 | 1 | $0 | 4 | Director | 04 Oct 2024, 16:06 |
| KALV | KalVista Pharmaceuticals, Inc. | 26 Sep 2023 | 1 | $0 | 4 | Director | 28 Sep 2023, 16:54 |
| KALV | KalVista Pharmaceuticals, Inc. | 13 Oct 2022 | 1 | $0 | 4 | Director | 17 Oct 2022, 18:36 |
| KALV | KalVista Pharmaceuticals, Inc. | 30 Sep 2021 | 1 | $0 | 4 | Director | 01 Oct 2021, 16:58 |